Correspondence 0001213900-24-045209 from CorMedix Inc. (CRMD) (CIK 0001410098) (CRMD)
CorMedix Inc. (CRMD) (CIK 0001410098)
Date: May 20, 2024 · CIK: 0001410098 · Accession: 0001213900-24-045209
AI Filing Summary & Sentiment
File numbers found in text: 333-279277
Letter
CorMedix Inc.
300 Connell Drive, Suite 4200
Berkeley Heights, NJ 07922
May 20, 2024
VIA EDGAR TRANSMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Division of Corporation Finance, Office of Life Sciences
Re: CorMedix Inc.
Registration Statement on Form S-3
Filed May 9, 2024
File No. 333-279277
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, CorMedix Inc. (the “Company”), hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-279277), so that such registration statement may become effective at 3:00 p.m. (Washington, D.C. time) on May 22, 2024, or as soon as practicable thereafter.
CORMEDIX INC.
By: /s/ Joe Todisco
Name: Joe Todisco
Title: Chief Executive Officer
Show Raw Text
CORRESP
1
filename1.htm
CorMedix Inc.
300 Connell Drive, Suite 4200
Berkeley Heights, NJ 07922
May 20, 2024
VIA EDGAR TRANSMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Division of
Corporation Finance, Office of Life Sciences
Re:
CorMedix Inc.
Registration Statement on Form S-3
Filed May 9, 2024
File No. 333-279277
Ladies and Gentlemen:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, CorMedix Inc. (the “Company”), hereby requests acceleration of the effective
date of its Registration Statement on Form S-3 (File No. 333-279277), so that such registration statement
may become effective at 3:00 p.m. (Washington, D.C. time) on May 22, 2024, or as soon as practicable thereafter.
CORMEDIX INC.
By:
/s/ Joe Todisco
Name: Joe Todisco
Title: Chief Executive Officer